Related Experiment Video
Updated: May 29, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation
Jorie Versmissen1, Ilse P G Botden, Roeland Huijgen
1Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Insights
Familial hypercholesterolemia (FH) inherited from mothers leads to significantly higher mortality than when inherited from fathers. This supports the fetal origin of adult disease, highlighting the need for maternal cholesterol management during pregnancy.
Area of Science:
- Cardiovascular Genetics
- Developmental Biology
- Epidemiology
Background:
- Maternal hypercholesterolemia during fetal development can increase atherosclerosis risk.
- Familial hypercholesterolemia (FH) is an inherited condition causing high LDL cholesterol.
- The impact of maternal vs. paternal inheritance of FH on long-term health outcomes is not fully understood.
Purpose of the Study:
- To investigate whether the parent of origin of familial hypercholesterolemia (FH) influences mortality risk.
- To test the hypothesis that maternal inheritance of FH is associated with more extreme CHD risk.
Main Methods:
- Analysis of a large Dutch pedigree with a known LDL receptor gene mutation (V408M).
- Studied 161 individuals across seven generations with known FH status and parental origin.
- Calculated standardized mortality ratios (SMR) and used Poisson regression to compare maternal and paternal FH inheritance.
Main Results:
- Maternal FH inheritance showed a significantly higher excess mortality (SMR 2.49) compared to paternal inheritance (SMR 1.30).
- Relative risk of excess mortality was 2.2 for maternal inheritance (p=0.048).
- Paternal FH inheritance did not show a statistically significant increase in mortality.
Conclusions:
- Inheriting familial hypercholesterolemia (FH) from the mother is linked to substantially increased all-cause mortality.
- Findings support the fetal origin of adult disease hypothesis, emphasizing prenatal influences on atherosclerosis.
- Further research is needed on safe cholesterol-lowering therapies for pregnant women with FH to mitigate adverse epigenetic effects in offspring.
Objective:
Fetal exposure to maternal hypercholesterolemia increases the extent of fatty-streak formation in fetal aortas as well as the rate of progression, and may therefore increase coronary heart disease (CHD) risk later in life. We hypothesized that the risk of CHD in untreated individuals with familial hypercholesterolemia (FH) is more extreme when the disease is transmitted maternally.
Methods:
In a large Dutch pedigree carrying the V408M mutation in the low-density lipoprotein (LDL) receptor gene, 161 individuals over seven generations were identified for which FH status and parent of origin of FH were known. We calculated standardized mortality ratios (SMR) and compared the consequences of maternal and paternal inheritance of FH by Poisson regression analysis.
Results:
Maternally inherited FH was associated with significantly higher excess mortality than FH transmitted by fathers (relative risk 2.2; p = 0.048): the SMR of maternal inheritance was 2.49 (95% confidence interval (CI) 1.45-3.99; p = 0.001), whereas it was not significantly increased in paternally inherited FH (SMR 1.30, 95% CI 0.65-2.32; p = 0.234).
Conclusion:
Mortality rates are more increased when FH is inherited through the mother, supporting the fetal origin of adulthood disease hypothesis with all cause death, the most indisputable outcome measure. Future research should explore safe options for cholesterol-lowering therapy of pregnant women with FH in order to prevent unfavourable (epigenetic) consequences leading to atherosclerosis in their children.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Animal Mitochondrial Genetics
Cholesterol: Significance and Regulation
Considering cholesterol and...

